Cited by 251Cardiac Health and Mental HealthTreatment of Major DepressionMental Health Treatment and Access

Depression and Cardiovascular Disease: Healing the Broken-Hearted

Open access
Whooley, Mary A.·2006·JAMA

Abstract

Major depressive disorder is a risk factor for the development of incident coronary heart disease events in healthy patients and for adverse cardiovascular outcomes in patients with established heart disease. Depression is present in 1 of 5 outpatients with coronary heart disease and in 1 of 3 outpatients with congestive heart failure, yet the majority of cases are not recognized or appropriately treated. It is not known whether treating depression improves cardiovascular outcomes, but antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression, and improves quality of life. This article evaluates the importance of major depression in patients with cardiovascular disease, and provides practical guidance for identifying and treating this disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.295.24.2874

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Depression is approximately twice as likely in individuals with coronary heart disease and 3 times as likely in persons with congestive heart failure compared to prevalence rates in the general population.

    “depression has been found to be approximately twice as likely in individuals with coronary heart disease and 3 times as likely in persons with congestive heart failure compared to prevalence rates in the general population”

    From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Whooley, 2006

    In “What Is the Best Way to Diagnose Depression in a Patient With Heart Disease?”, the paper gives depression prevalences of approximately 5% in the general population, 20% in CHD outpatients, and 30%–40% in heart-failure outpatients. Relative to the stated general-population rate, those figures are roughly fourfold and six- to eightfold—not twofold and threefold. (LLM, conf=0.89)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 103 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Skala, JA.; Freedland, KE.; Carney, RM. Heart Disease (Advances in Psychotherapy-Evidence- Based Practice). Hogrefe & Huber; Cambridge, Mass: 2005.

Cited by

Sorted by citations

Authors
Whooley, M. A.
Affiliations
San Francisco VA Medical Center (US)
Corresponding author
Whooley, Mary A.
Venue
JAMA
Published
2006-06-28
Volume
295
Issue
24
Pages
2874
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2171037771
Cited by
251
References
103
Citations by year
2026: 2 · 2025: 9 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 5 · 2017: 9 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 16 · 2012: 20
FWCI
15.71
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • Health Services Research and Development
  • University of California, San Francisco
  • National Heart, Lung, and Blood Institute (R01HL079235)
  • Department of Medicine, University of California, San Francisco
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
major depressive disorder, depression, cardiovascular disease, coronary artery disease, congestive heart failure, cardiovascular outcomes, antidepressant treatment, selective serotonin reuptake inhibitors, depression detection, quality of life
MeSH terms
Antidepressive Agents, Cardiovascular Diseases, Coronary Disease, Depressive Disorder, Major, Major Depressive Disorder, Humans, Male, Middle Aged, Psychotherapy, Quality of Life, Recurrence, Risk Factors, Comorbidity, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review